Skip to main content

Table 4 Clinician-assessed outcomes

From: Characteristics of the first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia: a cross-sectional observational study

Parameter Mean estimate Diff. 95 % CI p
Lower Upper
ROM (°) Control (ref.) 77.6     
Gout 59.7 −17.9 −26.8 −8.9 <0.001
Asymptomatic hyperuricaemia 76.8 −0.8 −9.3 7.7 0.853
Plantarflexion force (N) Control (ref.) 92.0     
Gout 71.3 −20.7 −36.9 −4.6 0.012
Asymptomatic hyperuricaemia 114.8 22.8 7.5 38.1 0.004
Dorsiflexion force (N) Control (ref.) 57.3     
Gout 58.0 0.8 −10.7 12.2 0.896
Asymptomatic hyperuricaemia 65.4 8.1 −2.7 19.0 0.139
Foot Posture Index Control (ref.) +4.8     
Gout +6.2 1.3 −0.4 3.1 0.134
Asymptomatic hyperuricaemia +6.6 1.8 0.1 3.4 0.036
Plantar temperature (°C) Control (ref.) 24.3     
Gout 26.2 1.9 0.6 3.1 0.004
Asymptomatic hyperuricaemia 25.1 0.8 −0.5 2.0 0.218
Dorsal temperature (°C) Control (ref.) 25.8     
Gout 27.7 1.9 0.6 3.1 0.003
Asymptomatic hyperuricaemia 26.5 0.6 −0.6 1.9 0.295
Medial temperature (°C) Control (ref.) 25.2     
  Gout 27.0 1.8 0.6 3.1 0.004
  Asymptomatic hyperuricaemia 25.9 0.8 −0.4 2.0 0.219
     95 % CI for OR p
  Lower Upper
Hallux Valgus Severitya Control (ref.)      
Gout   0.284 0.085 0.947 0.041
Asymptomatic hyperuricaemia 0.968 0.968 0.296 0.957  
  1. aReference category: none (i.e. grade 0). The odds ratio represents the odds of the diagnostic group moving up one category of severity, compared to the control group moving up one category of severity